Showing results (11-20 of 99) with videos related to
Sort By:
Pageof 10
International Journal of Pharmaceutics|December 8, 2010
Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapyHelen O McCarthy, Alek V Zholobenko, Yuhua Wang, et al.The Journal of Gene Medicine|December 9, 2008
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cellsCatherine Adams, Helen O McCarthy, Jonathan A Coulter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Evaluation of the antiangiogenic potential of AQ4NMartin O'Rourke, Claire Ward, Jenny Worthington, et al.Bioscience Reports|February 14, 2013
The contribution of N₂O₃ to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylationAhlam A Ali, Jonathan A Coulter, Claire H Ogle, et al.The Journal of Gene Medicine|February 16, 2005
A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4NVerna McErlane, Anita Yakkundi, Helen O McCarthy, et al.Plos One|March 5, 2013
The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathwayAnita Yakkundi, Lynn McCallum, Anthony O'Kane, et al.Cancer Gene Therapy|December 19, 2002
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4NHelen O McCarthy, Anita Yakkundi, Verna McErlane, et al.Pharmacology & Therapeutics|February 9, 2018
Targeting cancer stem cells in the clinic: Current status and perspectivesStephanie Annett, Tracy RobsonThe Journal of Pharmacy and Pharmacology|January 18, 2007
Targeting nitric oxide for cancer therapyDavid Hirst, Tracy RobsonCurrent Pharmaceutical Design|March 19, 2010
Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapyDavid Hirst, Tracy RobsonPageof 10